Skip to main content
OpenTrials
Completed

NCT Number: NCT03379532

BCI-controlled NMES in Subacute Stroke

Stroke patients with severe upper limb movement deficits have limited treatment options and often remain severely handicapped at the chronic stage.

Recent findings have suggested that poor motor recovery can be due to severe damage of the cortico-spinal tract (CST), the neural fibres connecting the movement regions of the brain to the spinal cord. Hence, to improve recovery of upper limb movements it will be crucial to re-establish and strengthen CST projections.

Recent studies provided evidence that closed-loop brain computer interface-driven electrical stimulation of the paretic muscles can induce clinically important and lasting recovery of upper limb function, even in patients with chronic, severe motor affection. In this treatment approach, movement intentions of the patients are detected with electroencephalography and real-time analyses. This triggers an electrical stimulation of affected upper limb muscles.

In this study, the investigators hypothesize that neuromuscular electrical stimulation (NMES) applied contingent to voluntary activation of primary motor cortex, as detected by a brain-computer interface (BCI), can help restore CST projections. This might improve recovery of patients with severe upper limb movement deficits. Treatment will be started within the first 8 weeks after stroke onset.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Division of Neurorehabilitation, University Hospital of Geneva, Geneva, Canton of Geneva, Switzerland

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Ischemic or hemorrhagic stroke
  • Stroke onset ≤ 8 weeks
  • Severe, unilateral motor upper extremity hemiparesis (≤15 Fugl-Meyer Score)
  • Ability to give informed consent

Exclusion criteria

  • Second stroke during rehabilitation
  • Skull breach
  • Cardiac pacemaker
  • Metallic implants in the brain
  • Delirium or disturbed vigilance
  • Inability to follow treatments sessions
  • Severe language comprehension deficits
  • Severe dystonia or spasticity
  • Severe co-morbidity (ex, traumatic, rheumatologic, neurodegenerative diseases)
  • Pregnancy

Treatment and study plan

BCI-NMES

Device

From the recorded brain activity (EEG) subject specific patterns will be extracted with machine learning techniques from recordings where the subject executes movements tasks. Whenever a subject-specific pattern can be identified and detected, this is used for triggering neuromuscular electrical stimulation.

Sham-NMES

Device

Neuromuscular electrical stimulation is triggered independently of the patient's movement intentions.

Primary outcomes

  1. Change in Upper Limb Fugl-Meyer Score, after treatment

    Time frame: Difference between the week before the intervention and the week after intervention

    Scale 0-66, higher scores indicate better outcome

Secondary outcomes

  1. Change in motor evoked potential amplitude of the paretic arm

    Time frame: Difference between the week before the intervention and the week after intervention

    Continuous measure, higher amplitude changes indicate better outcome

  2. Change in fractional anisotropy (FA) of the cortico-spinal tract as determined from diffusion tensor imaging

    Time frame: Difference between the week before the intervention and the week after intervention

    FA can have values between 0 and 1, higher values indicate better outcome

  3. Change in electroencephalography functional connectivity

    Time frame: Difference between the week before the intervention and the week after intervention

    Computed from high-density EEG recordings. Continuous measure. Higher values indicate better outcome.

Other outcomes

  1. Change in Upper Limb Fugl-Meyer Score, follow up

    Time frame: Difference between the week before intervention and 12 weeks after stroke onset

    Scale 0-66, higher scores indicate better outcome

  2. Change in hand grip strength, after intervention

    Time frame: Difference between the week before the intervention and the week after intervention

    Jamar dynamometer. Continous measure expressed in kilograms. Higher values indicate better outcome.

  3. Change in hand grip strength, follow up

    Time frame: Difference between the week before intervention and 12 weeks after stroke onset

    Jamar dynamometer. Continous measure expressed in kilograms. Higher values indicate better outcome.

  4. Change in Functional Independence Measure (FIM) score, after intervention

    Time frame: Difference between the week before the intervention and the week after intervention

    Range 18-126, higher values indicate better outcome.

  5. Change in Functional Independence Measure (FIM) score, follow up

    Time frame: Difference between the week before intervention and 12 weeks after stroke onset

    Range 18-126, higher values indicate better outcome.

  6. Change in Semmes-Weinstein monofilament discrimination test, after intervention

    Time frame: Difference between the week before the intervention and the week after intervention

    Range 0.04 to 60 g. Lower values indicate better outcome.

  7. Change in Semmes-Weinstein monofilament discrimination test, follow up

    Time frame: Difference between the week before intervention and 12 weeks after stroke onset

    Range 0.04 to 60 g. Lower values indicate better outcome.

  8. Change in Modified Ashworth Score, after intervention

    Time frame: Difference between the week before the intervention and the week after intervention

    Range 0 to 4. Lower values indicate better outcome.

  9. Change in Modified Ashworth Score, follow up

    Time frame: Difference between the week before intervention and 12 weeks after stroke onset

    Range 0 to 4. Lower values indicate better outcome.

  10. Change in action research arm test (ARAT) score, after intervention

    Time frame: Difference between the week before the intervention and the week after intervention

    Scale range 0-57 points, higher values indicate better outcome.

  11. Change in action research arm test (ARAT) score, follow up

    Time frame: Difference between the week before intervention and 12 weeks after stroke onset

    Scale range 0-57 points, higher values indicate better outcome.

Sponsors and collaborators

Lead sponsor

University Hospital, Geneva

Other

Collaborators

  • Clinique Romande de Readaptation
  • Ecole Polytechnique Fédérale de Lausanne

Registry information

Official study title

Brain-computer Interface Controlled Neuromuscular Electrical Stimulation in Subacute Stroke

Important dates

Study start
2018
Primary completion
2024
Study completion
2024
First posted
Dec 20, 2017
Registry last updated
May 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.